DK1926496T3 - PCV-2-vaccine - Google Patents

PCV-2-vaccine

Info

Publication number: DK1926496T3
Authority: DK; Denmark
Prior art keywords: pcv; vaccine
Prior art date: 2005-09-09

Application number

DK06793347.3T

Other languages

English (en)

Inventor

Frank Roerink

Woensel Peter Van

Original Assignee

Intervet Int Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-09

Filing date

2006-09-08

Publication date

2013-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35482131&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1926496(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-09-08 Application filed by Intervet Int Bv filed Critical Intervet Int Bv

2013-09-30 Application granted granted Critical

2013-09-30 Publication of DK1926496T3 publication Critical patent/DK1926496T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biotechnology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biophysics (AREA)
Mycology (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DK06793347.3T 2005-09-09 2006-09-08 PCV-2-vaccine DK1926496T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP05108299		2005-09-09
PCT/EP2006/066161 WO2007028823A1 (en)	2005-09-09	2006-09-08	Pcv-2 vaccine

Publications (1)

Publication Number	Publication Date
DK1926496T3 true DK1926496T3 (da)	2013-09-30

Family

ID=35482131

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06793347.3T DK1926496T3 (da)	2005-09-09	2006-09-08	PCV-2-vaccine

Country Status (14)

Country	Link
US (2)	US20080248061A1 (da)
EP (1)	EP1926496B1 (da)
JP (1)	JP5106398B2 (da)
KR (1)	KR101347503B1 (da)
CN (1)	CN101277717A (da)
AU (1)	AU2006289102C1 (da)
BR (1)	BRPI0615862A2 (da)
CA (1)	CA2620727C (da)
DK (1)	DK1926496T3 (da)
ES (1)	ES2425228T3 (da)
PL (1)	PL1926496T3 (da)
RU (1)	RU2389506C2 (da)
UA (1)	UA95458C2 (da)
WO (1)	WO2007028823A1 (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL2460820T3 (pl) *	2004-12-30	2019-09-30	Boehringer Ingelheim Animal Health USA Inc.	Immunogenne kompozycje PCV2 stosowane w zapobieganiu infekcjom PCV2
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en)	2005-12-29	2010-04-20	Boehringer Ingelheim Vetmedica, Inc.	PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
PT2275132T (pt)	2005-12-29	2021-05-21	Boehringer Ingelheim Animal Health Usa Inc	Composições imunogénicas de pcv2 multivalentes e métodos para produzir composições deste tipo
MX2008008311A (es) *	2005-12-29	2009-03-04	Boehringer Ingelheim Vetmed	Uso de una composicion inmunogenica de pcv2 para reducir los sintomas clinicos en cerdos.
EP2101815A4 (en)	2006-12-11	2010-10-06	Boehringer Ingelheim Vetmed	EFFICIENT PROCESS FOR THE TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS
EP2094872B2 (en)	2006-12-15	2020-02-19	Boehringer Ingelheim Animal Health USA Inc.	Treatment of anti-PCV2 antibody seropositive pigs with PCV2 antigen
EP1941903A1 (en)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
US7829274B2 (en)	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
AU2009234345B2 (en)	2008-01-23	2013-08-22	Boehringer Ingelheim Vetmedica, Inc.	PCV2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
TWI449533B (zh)	2008-04-18	2014-08-21	Intervet Int Bv	防備胞內勞森菌（Ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅｃｉｒｃｏｖｉｒｕｓ）用疫苗
TWI551295B (zh)	2008-04-18	2016-10-01	英特威特國際股份有限公司	防備胞內勞森菌（Ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
AR078253A1 (es)	2009-09-02	2011-10-26	Boehringer Ingelheim Vetmed	Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
CN101875941A (zh) *	2010-03-09	2010-11-03	胡文锋	一种人工改造合成的dORF2art基因及其编码的蛋白质
AU2010357208A1 (en)	2010-07-08	2013-02-21	United Biomedical, Inc.	Designer peptide-based PCV2 vaccine
CN101920012B (zh) *	2010-07-22	2012-12-12	普莱柯生物工程股份有限公司	利用家蚕生物反应器生产猪圆环病毒2型重组衣壳蛋白亚单位疫苗的方法及其产品
WO2012076623A1 (en)	2010-12-08	2012-06-14	Intervet International B.V.	A method to quantify the amount of a biological substance in a sample and a kit for performing the method
EP2564869A1 (en)	2011-09-02	2013-03-06	Ceva Sante Animale	Synthetic capsid proteins and uses thereof
CN102352347A (zh) *	2011-10-14	2012-02-15	浙江诺倍威生物技术有限公司	Pcv2重组杆状病毒构建及其亚单位疫苗制备方法
CN102517331A (zh) *	2011-12-26	2012-06-27	武汉中博生物股份有限公司	一种猪圆环病毒2型亚单位疫苗及其制备方法和其应用
UA114504C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
CN102978232B (zh) *	2012-08-23	2014-07-16	郑州后羿制药有限公司	一种IPTG诱导猪圆环病毒2型重组Cap蛋白表达的方法
BR102013001893B1 (pt)	2013-01-25	2022-01-25	Fundação De Amparo À Pesquisa Do Estado De Minas Gerais - Fapemig	Antígenos recombinantes do porcine circovirus 2 (pcv-2) para formulações vacinais, kit de diagnóstico e uso
EP2994162B1 (en)	2013-05-08	2021-04-07	Pharmgate Biologics Inc.	Vaccine for pcv2 and mycoplasma
KR101527832B1 (ko) *	2013-05-28	2015-06-11	대한민국	돼지써코바이러스 2형(pcv2)의 orf2 재조합 유전자, 전달 벡터, 재조합 배큘로바이러스, 돼지써코바이러스 2형(pcv2) 재조합 캡시드 단백질 및 그의 제조방법
KR102319843B1 (ko) *	2013-09-25	2021-10-29	조에티스 서비시즈 엘엘씨	Pcv2b 분지형 백신 조성물 및 사용 방법
AR097762A1 (es)	2013-09-27	2016-04-13	Intervet Int Bv	Formulaciones secas de vacunas que son estables a temperatura ambiente
MX373884B (es)	2013-10-02	2020-03-26	Boehringer Ingelheim Animal Health Usa Inc	Variante de la proteína pcv2 orf2 y partículas similares al virus compuestas por ésta.
CN104548083B (zh) *	2013-10-22	2019-05-07	洛阳赛威生物科技有限公司	一种疫苗组合物及其制备方法和应用
JP6488304B2 (ja)	2013-12-03	2019-03-20	インターベットインターナショナルベー．フェー．	ローソニア・イントラセルラリス（ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）及びブタサーコウイルス（ｐｏｒｃｉｎｅｃｉｒｃｏｖｉｒｕｓ）２に対するワクチン
ES2771899T3 (es)	2013-12-03	2020-07-07	Intervet Int Bv	Vacuna contra circovirus porcino de tipo 2
RU2731845C2 (ru) *	2014-12-11	2020-09-08	Интервет Интернэшнл Б.В.	СПОСОБ ПОЛУЧЕНИЯ ГОТОВОЙ К ПРИМЕНЕНИЮ КОМБИНИРОВАННОЙ ВАКЦИНЫ ПРОТИВ PCV2/M.hyo
US11654191B2 (en)	2016-03-23	2023-05-23	Intervet Inc.	Vaccine for intradermal application against PCV2 and PRRS virus infection
US10953084B2 (en)	2016-03-23	2021-03-23	Intervet Inc.	Combination vaccine against PCV2 and PRRS virus infection comprising albumin
WO2017162741A1 (en)	2016-03-23	2017-09-28	Intervet International B.V.	A combination vaccine against pcv2 virus and mycoplasma hyopneumoniae infection
CN105785037B (zh) *	2016-03-30	2017-09-19	中国农业科学院兰州兽医研究所	猪圆环病毒2型抗体快速检测层析试纸条及制备方法
US11311614B2 (en)	2017-04-13	2022-04-26	Intervet Inc.	Vaccines containing swine pathogens for associated non-mixed use
WO2019022463A2 (ko) *	2017-07-24	2019-01-31	(주)제이비바이오텍	면역원성시스템 및 이를 포함한 동물 백신
EP3661548B1 (en)	2017-08-03	2024-06-26	Intervet International B.V.	A vaccine comprising a pcv2 orf2 protein of genotype 2b
WO2019076864A1 (en)	2017-10-17	2019-04-25	Intervet International B.V.	RECOMBINANT EXPRESSION OF PCV2B ORF2 PROTEIN IN INSECT CELLS
JP7162072B2 (ja)	2018-03-26	2022-10-27	ベーリンガーインゲルハイムアニマルヘルスユーエスエイインコーポレイテッド	免疫原性組成物を製造する方法
BR112022004256A2 (pt)	2019-09-12	2022-06-21	Intervet Int Bv	Vacina de combinação para administração intradérmica
JP2023523405A (ja)	2020-04-20	2023-06-05	インターベットインターナショナルベー．フェー．	予防的にブタを治療するワクチンの組み合わせ
WO2022090357A1 (en)	2020-10-29	2022-05-05	Intervet International B.V.	Combination vaccine for protecting swine against various disorders
WO2024228149A2 (en)	2023-05-03	2024-11-07	Boehringer Ingelheim Vetmedica Gmbh	Method for inducing an immune response
WO2024228148A1 (en)	2023-05-03	2024-11-07	Boehringer Ingelheim Vetmedica Gmbh	Immunogenic composition useful for self-administration by pigs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2068989T3 (es) *	1989-02-04	1995-05-01	Akzo Nobel Nv	Tocoles como adyuvante en vacunas.
EP0835930B1 (en) *	1996-10-09	2001-01-31	Akzo Nobel N.V.	European vaccine strains of the porcine reproductive and respiratory syndrome virus (PRRSV)
AUPO856097A0 (en) *	1997-08-14	1997-09-04	Commonwealth Scientific And Industrial Research Organisation	Vector
US6517843B1 (en) *	1999-08-31	2003-02-11	Merial	Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2772047B1 (fr) *	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US20040062775A1 (en) *	1997-12-05	2004-04-01	Agence Francaise De Securite Sanitaire Des Aliments	Circovirus sequences associated with piglet weight loss disease (PWD)
US7276353B2 (en) *	2001-12-12	2007-10-02	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7691368B2 (en) *	2005-04-15	2010-04-06	Merial Limited	Vaccine formulations

2006
- 2006-09-08 AU AU2006289102A patent/AU2006289102C1/en active Active
- 2006-09-08 UA UAA200803112A patent/UA95458C2/ru unknown
- 2006-09-08 ES ES06793347T patent/ES2425228T3/es active Active
- 2006-09-08 CA CA2620727A patent/CA2620727C/en active Active
- 2006-09-08 JP JP2008529638A patent/JP5106398B2/ja active Active
- 2006-09-08 BR BRPI0615862-5A patent/BRPI0615862A2/pt not_active Application Discontinuation
- 2006-09-08 CN CNA2006800368680A patent/CN101277717A/zh active Pending
- 2006-09-08 DK DK06793347.3T patent/DK1926496T3/da active
- 2006-09-08 RU RU2008113763/15A patent/RU2389506C2/ru active
- 2006-09-08 EP EP06793347.3A patent/EP1926496B1/en not_active Revoked
- 2006-09-08 KR KR1020087007927A patent/KR101347503B1/ko active Active
- 2006-09-08 PL PL06793347T patent/PL1926496T3/pl unknown
- 2006-09-08 US US12/066,090 patent/US20080248061A1/en active Granted
- 2006-09-08 WO PCT/EP2006/066161 patent/WO2007028823A1/en active Application Filing
2009
- 2009-12-11 US US12/636,143 patent/US8008001B2/en active Active

Also Published As

Publication number	Publication date
JP5106398B2 (ja)	2012-12-26
EP1926496A1 (en)	2008-06-04
CA2620727A1 (en)	2007-03-15
US20080248061A1 (en)	2008-10-09
ES2425228T3 (es)	2013-10-14
AU2006289102C1 (en)	2017-11-30
US20110064765A1 (en)	2011-03-17
KR101347503B1 (ko)	2014-01-02
EP1926496B1 (en)	2013-06-26
JP2009507811A (ja)	2009-02-26
RU2008113763A (ru)	2009-10-20
AU2006289102A1 (en)	2007-03-15
RU2389506C2 (ru)	2010-05-20
CN101277717A (zh)	2008-10-01
KR20080042159A (ko)	2008-05-14
UA95458C2 (ru)	2011-08-10
AU2006289102B2 (en)	2011-12-15
PL1926496T3 (pl)	2014-02-28
US8008001B2 (en)	2011-08-30
BRPI0615862A2 (pt)	2011-05-31
WO2007028823A1 (en)	2007-03-15
CA2620727C (en)	2015-06-16

Publication	Publication Date	Title
DK1926496T3 (da)	2013-09-30	PCV-2-vaccine
DK1968631T3 (da)	2015-06-15	Vaccine
DK1959991T3 (da)	2013-06-17	Terapeutisk vaccine
ATE450271T1 (de)	2009-12-15	Impfstoff
EP1917040A4 (en)	2012-12-12	VACCINE VERSATILE
EP1929953A4 (en)	2009-03-18	ULTRASOUND DEVICE
FI20060708L (fi)	2007-05-01	Hierontalaite
DE602006012626D1 (de)	2010-04-15	Mischmaschine
DE602006012066D1 (de)	2010-03-18	Daraus
EP1852622A4 (en)	2009-12-30	CONICAL DISK SPRING
DE502006006857D1 (de)	2010-06-10	Wingungserregern
DK1848727T3 (da)	2015-07-20	Ibandronat polymorf b
DE602006000564D1 (de)	2008-04-10	Kindermatraze
EP1961384A4 (en)	2011-04-27	ULTRASOUND DEVICE
EP1916896A4 (en)	2010-08-11	NOT STEROID-antiandrogens
DK1948360T3 (da)	2009-06-02	Valsemölle
EP1959487A4 (en)	2009-12-23	SURFACE RUGOSIMETER
DE602006000139D1 (de)	2007-11-15	Biderzeugungsvorrichtung
FI20055715A0 (fi)	2005-12-30	Turboekvalisointimenettely
DE602006007654D1 (de)	2009-08-20	Flüssigkeitejektionsgerät
DK1877549T3 (da)	2011-02-14	HIV-vaccine
DE502005005839D1 (de)	2008-12-11	Feldgeerät
DE502006003210D1 (de)	2009-04-30	Nohydrogenpolysiloxanen
DE602005008023D1 (de)	2008-08-21	Originalitätssprühkappe
NO20051706L (no)	2006-10-09	Snepplas